Prescription drug · NDA
Symproic (Naldemedine) NDC 59385-041
Naldemedine tosylate .2 mg/1 · Tablet · Oral · BioDelivery Sciences International Inc
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 59385-041-30 | 59385004130 | 30 TABLET in 1 BOTTLE, PLASTIC (59385-041-30)Marketed from Jun 14, 2019 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Symproic
- Generic name (nonproprietary)
- naldemedine
- Active ingredients
- Naldemedine tosylate — .2 mg/1
- Dosage form
- Tablet
- Route
- Oral
- Labeler
- BioDelivery Sciences International IncNDC labeler code 59385
- Product type
- Prescription drug
- Marketing category
- NDA — New Drug ApplicationApplication NDA 208854
- Marketing start
- Listing expires
- Other FDA classes
- Opioid Antagonists (Mechanism)
- Identifiers
- Product ID 59385-041_7ce44be3-47a7-411e-ad1f-a2efc4916425SPL ID 7ce44be3-47a7-411e-ad1f-a2efc4916425SPL set ID b1a1256c-a1eb-4abe-ab1e-30e4711afd16RxCUI 1876603, 1876609UNII V1N8F1RVVOUPC 0359385041307
- Pharmacologic class
- Opioid Antagonist
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N459385004130followed by a unit qualifier and the quantityPackage 59385-0041-30. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
SYMPROIC is indicated for the treatment of opioid-induced constipation (OIC) in adult patients with chronic non-cancer pain, including patients with chronic pain related to prior cancer or its treatment who do not require frequent (e.g., weekly) opioid dosage escalation. SYMPROIC is an opioid antagonist indicated for the treatment of opioid-induced constipation (OIC) in adult patients with chronic non-cancer pain, including patients with chronic pain related to prior cancer or its treatment who do not require frequent (e.g., weekly) opioid dosage escalation ( 1 )
Excerpt only. Read the full label for complete information.
About NDC 59385-041
- What is NDC 59385-041?
- 59385-041 is the product NDC for Symproic (naldemedine), Naldemedine tosylate .2 mg/1 tablet, listed with the FDA by BioDelivery Sciences International Inc. It has 1 package NDC, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Symproic (Naldemedine).
- What is the active ingredient?
- Naldemedine tosylate.
- Who is the labeler?
- BioDelivery Sciences International Inc, NDC labeler code 59385. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Symproic?
- None: this is the only finished product listed under this name.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.